| Citation: |
LI Jingjing, JIANG Daishan, ZHANG Xia, CHEN Yu, HUANG Zhongwei. Correlation between blood glucose level on admission and prognosis in patients with sepsis[J]. Journal of Clinical Medicine in Practice, 2023, 27(5): 104-109. DOI: 10.7619/jcmp.20223231
|
To explore the correlation between blood glucose level on admission and prognosis in patients with sepsis.
A total of 290 hospitalized patients with sepsis in the Emergency Department of Affiliated Hospital of Nantong University from April 2016 to October 2021 were selected, and they were divided into normal blood glucose group (blood glucose level ranged from 4.0 to 7.7 mmol/L) with 116 cases, mild hyperglycemia group (blood glucose level ranged from greater than 7.7 to 11.0 mmol/L) with 95 cases, and severe hyperglycemia group (blood glucose level was greater than 11.0 mmol/L) with 79 cases according to the blood glucose level on admission, and hypoglycemia group was excluded. Restricted cubic spline curve was used to analyze the relationship between blood glucose level and 28-day mortality; the Logistic regression model was used to analyze the correlation between blood glucose grade and 28-day mortality; subgroup analysis was performed based on the presence or absence of previous hypertension and diabetes.
Of the 290 patients, 70 cases (24.1%) died within 28 days. Compared with the survival group (n=220), the age, the Sequential Organ Failure Score (SOFA) and the Acute Physiology and Chronic Health Evaluation(APACHE Ⅱ) score of patients in the death group were significantly higher (P < 0.05). In the comparison of baseline characteristic materials between normal blood glucose group, mild hyperglycemia group and severe hyperglycemia group, the results showed that with the aggravation of hyperglycemia severity, the previous prevalence rates of hypertension and diabetes were significantly higher (P=0.01, P < 0.01), while the prothrombin time (PT) and activated partial thrombin time (APTT) significantly shortened (P < 0.01); the 28-day mortalities of the three groups were 18.1%, 22.1% and 35.4% respectively, and there was significant difference among three groups (P=0.02). With the increase of blood glucose level, the risk of 28-day mortality increased in a linear relationship (non-linear test P=0.856); the univariate Logistic regression analysis showed that increases of age, SOFA score and APACHE Ⅱ score as well as increased degree of blood glucose level were correlated with 28-day mortality (P < 0.05); in both model 1 and model 2 established by multivariate regression analysis, severe hyperglycemia was independently associated with 28-day mortality (OR=2.48, 3.38; 95%CI, 1.25 to 4.95, 1.50 to 7.63); the subgroup analysis for the presence or absence of previous hypertension and diabetes showed no significant interaction (P>0.05).
Severe hyperglycemia on hospital admission in patients with sepsis is associated with increased risk of 28-day mortality, which should be considered seriously by clinicians.
| [1] |
SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The third international consensus definitions for Sepsis and septic shock (Sepsis-3)[J]. JAMA, 2016, 315(8): 801-810. doi: 10.1001/jama.2016.0287
|
| [2] |
RUDD K E, JOHNSON S C, AGESA K M, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study[J]. Lancet, 2020, 395(10219): 200-211. doi: 10.1016/S0140-6736(19)32989-7
|
| [3] |
LELUBRE C, VINCENT J L. Mechanisms and treatment of organ failure in sepsis[J]. Nat Rev Nephrol, 2018, 14(7): 417-427. doi: 10.1038/s41581-018-0005-7
|
| [4] |
秦妮, 米婷, 段亚楠. 脓毒症患者28 d死亡率的相关因素分析[J]. 实用临床医药杂志, 2019, 23(14): 76-79. doi: 10.7619/jcmp.201914020
|
| [5] |
孟祥忠, 张晓宁, 朱宇, 等. 重症脓毒症休克患者免疫状况的临床分析[J]. 实用临床医药杂志, 2018, 22(1): 4-6. doi: 10.7619/jcmp.201801002
|
| [6] |
VAN VUGHT L A, WIEWEL M A, KLEIN KLOUWENBERG P M, et al. Admission hyperglycemia in critically ill Sepsis patients: association with outcome and host response[J]. Crit Care Med, 2016, 44(7): 1338-1346. doi: 10.1097/CCM.0000000000001650
|
| [7] |
BADAWI O, WAITE M D, FUHRMAN S A, et al. Association between intensive care unit-acquired dysglycemia and in-hospital mortality[J]. Crit Care Med, 2012, 40(12): 3180-3188. doi: 10.1097/CCM.0b013e3182656ae5
|
| [8] |
HUANG M, CAI S L, SU J Q. The pathogenesis of Sepsis and potential therapeutic targets[J]. Int J Mol Sci, 2019, 20(21): 5376. doi: 10.3390/ijms20215376
|
| [9] |
INGELS C, GUNST J, VAN DEN BERGHE G. Endocrine and metabolic alterations in Sepsis and implications for treatment[J]. Crit Care Clin, 2018, 34(1): 81-96. doi: 10.1016/j.ccc.2017.08.006
|
| [10] |
MIFSUD S, SCHEMBRI E L, GRUPPETTA M. Stress-induced hyperglycaemia[J]. Br J Hosp Med (Lond), 2018, 79(11): 634-639. doi: 10.12968/hmed.2018.79.11.634
|
| [11] |
WANG W, CHEN W W, LIU Y M, et al. Blood glucose levels and mortality in patients with Sepsis: dose-response analysis of observational studies[J]. J Intensive Care Med, 2021, 36(2): 182-190. doi: 10.1177/0885066619889322
|
| [12] |
LU Z Q, TAO G, SUN X Y, et al. Association of blood glucose level and glycemic variability with mortality in Sepsis patients during ICU hospitalization[J]. Front Public Health, 2022, 10: 857368. doi: 10.3389/fpubh.2022.857368
|
| [13] |
张玲玲, 王颖. 糖尿病和入院高血糖对严重脓毒症患者预后的影响[J]. 临床急诊杂志, 2020, 21(4): 323-326. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC202004014.htm
|
| [14] |
LIN S, LAI D F, HE W M. Association between hyperglycemia and adverse clinical outcomes of sepsis patients with diabetes[J]. Front Endocrinol (Lausanne), 2023, 13: 1046736. doi: 10.3389/fendo.2022.1046736
|
| [15] |
王皓, 王昀, 陈红, 等. 血糖变化对ICU脓毒症患者预后的影响[J]. 临床急诊杂志, 2021, 22(9): 575-581. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC202109002.htm
|
| [16] |
STEGENGA M E, VINCENT J L, VAIL G M, et al. Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis[J]. Crit Care Med, 2010, 38(2): 539-545. doi: 10.1097/CCM.0b013e3181c02726
|
| [17] |
LIN S, GE S H, HE W M, et al. Association between comorbid diabetes mellitus and prognosis of patients with sepsis in the intensive care unit: a retrospective cohort study[J]. Ann Transl Med, 2021, 9(1): 22. doi: 10.21037/atm-20-4360
|
| [18] |
AMERICAN DIABETES ASSOCIATION. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2021[J]. Diabetes Care, 2021, 44(Suppl 1): S15-S33.
|
| [19] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华内分泌代谢杂志, 2021, 37(4): 311-398. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYX202112018.htm
|
| [20] |
PLUMMER M P, DEANE A M. Dysglycemia and glucose control during Sepsis[J]. Clin Chest Med, 2016, 37(2): 309-319.
|
| [21] |
VIANA M V, MORAES R B, FABBRIN A R, et al. Assessment and treatment of hyperglycemia in critically ill patients[J]. Rev Bras Ter Intensiva, 2014, 26(1): 71-76.
|
| [22] |
STEGENGA M E, VAN DER CRABBEN S N, BLVMER R M, et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia[J]. Blood, 2008, 112(1): 82-89.
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: